Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agapios Sachinidis

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
EXCLI Journal|April 6, 2016
Highlight report: Cardiotoxicity screeningAgapios Sachinidis
Signal Transduction and Targeted Therapy|June 6, 2021
High-throughput base editing: a promising technology for precision medicine and drug discoveryAgapios Sachinidis
Cells|April 23, 2020
Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer DrugsAgapios Sachinidis
Drug News & Perspectives|April 5, 2003
Are Catechins Natural Tyrosine Kinase Inhibitors?Agapios Sachinidis, Jurgen Hescheler
Current Vascular Pharmacology|August 24, 2004
Possible non-classic intracellular and molecular mechanisms of LDL cholesterol action contributing to the development and progression of atherosclerosisIoanna Gouni-Berthold, Agapios Sachinidis
Cells|May 5, 2019
Current Challenges of iPSC-Based Disease Modeling and Therapeutic ImplicationsMichael Xavier Doss, Agapios Sachinidis
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2002
Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?Ioanna Gouni-Berthold, Agapios Sachinidis
Drug News & Perspectives|April 5, 2003
Inhibition of the Low Density Lipoprotein-Induced Vascular Smooth Muscle Cell Growth by PPARgamma LigandsIoanna Gouni-Berthold, Agapios Sachinidis
Biochimica Et Biophysica Acta|June 14, 2005
Embryonic stem cells for basic research and potential clinical applications in cardiologyJohannes Winkler, Jürgen Hescheler, Agapios Sachinidis
Frontiers in Cardiovascular Medicine|May 14, 2021
Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer DrugsPanagiota Papazoglou, Luying Peng, Agapios Sachinidis
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
EXCLI Journal|April 6, 2016
Highlight report: Cardiotoxicity screeningAgapios Sachinidis
Signal Transduction and Targeted Therapy|June 6, 2021
High-throughput base editing: a promising technology for precision medicine and drug discoveryAgapios Sachinidis
Cells|April 23, 2020
Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer DrugsAgapios Sachinidis
Drug News & Perspectives|April 5, 2003
Are Catechins Natural Tyrosine Kinase Inhibitors?Agapios Sachinidis, Jurgen Hescheler
Current Vascular Pharmacology|August 24, 2004
Possible non-classic intracellular and molecular mechanisms of LDL cholesterol action contributing to the development and progression of atherosclerosisIoanna Gouni-Berthold, Agapios Sachinidis
Cells|May 5, 2019
Current Challenges of iPSC-Based Disease Modeling and Therapeutic ImplicationsMichael Xavier Doss, Agapios Sachinidis
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2002
Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?Ioanna Gouni-Berthold, Agapios Sachinidis
Drug News & Perspectives|April 5, 2003
Inhibition of the Low Density Lipoprotein-Induced Vascular Smooth Muscle Cell Growth by PPARgamma LigandsIoanna Gouni-Berthold, Agapios Sachinidis
Biochimica Et Biophysica Acta|June 14, 2005
Embryonic stem cells for basic research and potential clinical applications in cardiologyJohannes Winkler, Jürgen Hescheler, Agapios Sachinidis
Frontiers in Cardiovascular Medicine|May 14, 2021
Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer DrugsPanagiota Papazoglou, Luying Peng, Agapios Sachinidis
Pageof 19